IRIS Accounts Production v26.1.0.640 15861770 director 27.7.24 31.7.25 31.7.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh158617702024-07-26158617702025-07-31158617702024-07-272025-07-31158617702024-07-2615861770ns15:EnglandWales2024-07-272025-07-3115861770ns14:PoundSterling2024-07-272025-07-3115861770ns10:Director12024-07-272025-07-3115861770ns10:PrivateLimitedCompanyLtd2024-07-272025-07-3115861770ns10:SmallEntities2024-07-272025-07-3115861770ns10:AuditExempt-NoAccountantsReport2024-07-272025-07-3115861770ns10:SmallCompaniesRegimeForDirectorsReport2024-07-272025-07-3115861770ns10:SmallCompaniesRegimeForAccounts2024-07-272025-07-3115861770ns10:FullAccounts2024-07-272025-07-3115861770ns5:CurrentFinancialInstruments2025-07-3115861770ns5:ShareCapital2025-07-3115861770ns5:RetainedEarningsAccumulatedLosses2025-07-3115861770ns10:RegisteredOffice2024-07-272025-07-3115861770ns5:FurnitureFittings2024-07-272025-07-3115861770ns5:FurnitureFittings2025-07-3115861770ns5:WithinOneYearns5:CurrentFinancialInstruments2025-07-31
REGISTERED NUMBER: 15861770 (England and Wales)















KAYANI MED LTD

UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD 27 JULY 2024 TO 31 JULY 2025






KAYANI MED LTD (REGISTERED NUMBER: 15861770)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE PERIOD 27 JULY 2024 TO 31 JULY 2025










Page

Balance sheet 1

Notes to the financial statements 3


KAYANI MED LTD (REGISTERED NUMBER: 15861770)

BALANCE SHEET
31 JULY 2025

Notes £    £   
FIXED ASSETS
Tangible assets 4 2,286

CURRENT ASSETS
Debtors 5 9,595
Cash at bank 467
10,062
CREDITORS
Amounts falling due within one year 6 9,162
NET CURRENT ASSETS 900
TOTAL ASSETS LESS CURRENT LIABILITIES 3,186

CAPITAL AND RESERVES
Called up share capital 100
Retained earnings 3,086
3,186

KAYANI MED LTD (REGISTERED NUMBER: 15861770)

BALANCE SHEET - continued
31 JULY 2025


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 July 2025.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 July 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of income and retained earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 23 April 2026 and were signed by:





Dr S Kayani - Director


KAYANI MED LTD (REGISTERED NUMBER: 15861770)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD 27 JULY 2024 TO 31 JULY 2025


1. STATUTORY INFORMATION

Kayani Med Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 15861770

Registered office: Millhouse
32-38 East Street
Rochford
Essex
SS4 1DB

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Revenue
Revenue is recognised to the extent that it is probable that the economic benefits will flow to the company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services
Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
- the amount of revenue can be measured reliably;
- it is probable that the company will receive the consideration due under the contract;
- the stage of completion of the contract at the end of the reporting period can be measured reliably; and
- the costs incurred and the costs to complete the contract can be measured reliably.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

KAYANI MED LTD (REGISTERED NUMBER: 15861770)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 27 JULY 2024 TO 31 JULY 2025


2. ACCOUNTING POLICIES - continued

Financial instruments
The company has elected to apply the provisions of Section 11 "Basic Financial Instruments" of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's Balance Sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The company's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments.

Impairment of financial assets
At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset's original effective interest rate. The impairment loss is recognised in profit or loss.

Financial assets are impaired when events, subsequent to their initial recognition, indicate the estimated future cash flows derived from the financial asset(s) have been adversely impacted. The impairment loss will be the difference between the current carrying amount and the present value of the future cash flows at the asset(s) original effective interest rate.

If there is a favourable change in relation to the events surrounding the impairment loss then the impairment can be reviewed for possible reversal. The reversal will not cause the current carrying amount to exceed the original carrying amount had the impairment not been recognised. The impairment reversal is recognised in the profit or loss.

Basic financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other creditors, bank loans and other loans are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through profit and loss). When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial.
Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.


KAYANI MED LTD (REGISTERED NUMBER: 15861770)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 27 JULY 2024 TO 31 JULY 2025


2. ACCOUNTING POLICIES - continued
Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment is due within one year. If not, they represent non current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

Derecognition of financial assets
Financial assets are derecognised when their contractual right to future cash flow expire, or are settled, or when the company transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the company will continue to recognise the value of the portion of the risks and rewards retained.

Derecognition of financial liabilities
Financial liabilities are derecognised when the company's contractual obligations expire or are discharged or cancelled.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 1 .

4. TANGIBLE FIXED ASSETS
Fixtures
and
fittings
£   
COST
Additions 2,442
At 31 July 2025 2,442
DEPRECIATION
Charge for period 156
At 31 July 2025 156
NET BOOK VALUE
At 31 July 2025 2,286

KAYANI MED LTD (REGISTERED NUMBER: 15861770)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 27 JULY 2024 TO 31 JULY 2025


5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Trade debtors 9,595

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Taxation and social security 6,287
Other creditors 2,875
9,162